ClinicalTrials.Veeva

Menu

Studying of Natural Constituents' Treatment of Plantar Warts

D

Deraya University

Status and phase

Completed
Early Phase 1

Conditions

Plantar Wart

Treatments

Drug: Banaba Leaf Extract

Study type

Interventional

Funder types

Other

Identifiers

NCT05592041
Anti-HPV

Details and patient eligibility

About

Moringa banana nigella and Banna coat extract were prepared and formulated in the form of bi gel for transdermal delivery of these plant extracts. The formulation was prepared and charterized for organoleptic charters, morphology, and penetration efficacy. The optimised formulation was assessed clinically on patients suffering from plantar warts. The clinical study was phase 1 and interventional randomised allocation.

Enrollment

20 patients

Sex

All

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female patient aged 18 years or more.
  • Clinical evaluation
  • Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm

Exclusion criteria

  • Patient suspected to be immunocompromised
  • Patient aged under 18 years
  • Patient refusing to sign the consent
  • Pregnant or lactating women

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Treatment group (Group I)
Experimental group
Treatment:
Drug: Banaba Leaf Extract
Control group (Group II)
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems